Symbols / ACB Stock $2.92 -2.67% Aurora Cannabis Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • Canada • NCM
ACB (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Miguel Martin
Exch · Country NCM · Canada
Market Cap 180.87M
Enterprise Value 92.78M
Income -58.62M
Sales 320.59M
FCF (ttm) 8.99M
Book/sh 6.77
Cash/sh 1.89
Employees 1,028
Insider 10d —
IPO Jul 15, 2014
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -26.55
PEG —
P/S 0.56
P/B 0.43
P/C —
EV/EBITDA -2.81
EV/Sales 0.29
Quick Ratio 2.41
Current Ratio 5.94
Debt/Eq 4.66
LT Debt/Eq —
EPS (ttm) -0.74
EPS next Y -0.11
EPS Growth —
Revenue Growth 5.10%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-06-11
ROA -4.01%
ROE -10.46%
ROIC —
Gross Margin 42.62%
Oper. Margin -26.39%
Profit Margin -42.41%
Shs Outstand 61.94M
Shs Float 61.64M
Insider Own 0.00%
Instit Own 10.61%
Short Float —
Short Ratio 10.58
Short Interest 7.29M
52W High 6.67
vs 52W High -56.19%
52W Low 2.73
vs 52W Low 6.96%
Beta 1.34
Impl. Vol. 12.50%
Rel Volume 1.56
Avg Volume 1.04M
Volume 1.62M
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom Buy
Prev Close $3.00
Price $2.92
Change -2.67%
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$2.92
Latest analyst target
3. DCF / Fair value
$2.61
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.92
Low
—
High
—
Mean
—
News
RSS: Latest ACB news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-31 Miller (Alex) Senior Officer of Issuer — 2,338 — —
2025-09-23 Martin (Miguel) Senior Officer of Issuer — 60,024 — —
2025-09-23 Schick (Lori) Senior Officer of Issuer — 13,265 — —
2025-09-23 Schick (Lori) Senior Officer of Issuer — 7,352 $5.12 $37,627
2025-09-19 Martin (Miguel) Senior Officer of Issuer — 860 — —
2025-06-27 Martin (Miguel) Senior Officer of Issuer — 22,951 — —
2025-06-20 Jerome (Andre) Senior Officer of Issuer — 8,000 $4.24 $33,960
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2022-06-30
Total Revenue
320.59
+10.97%
288.91
+7.15%
269.64
+21.82%
221.34
Operating Revenue
342.42
+7.06%
319.86
+6.91%
299.18
+18.11%
253.30
Cost Of Revenue
183.94
+70.38%
107.96
-21.72%
137.91
-31.09%
200.11
Reconciled Cost Of Revenue
173.56
+76.50%
98.34
-16.03%
117.11
-24.47%
155.06
Gross Profit
136.65
-24.48%
180.95
+37.37%
131.73
+520.63%
21.23
Operating Expense
183.31
+7.50%
170.52
+4.75%
162.78
-32.34%
240.60
Research And Development
4.02
+9.41%
3.68
+2.91%
3.57
-65.62%
10.39
Selling General And Administration
173.50
+8.15%
160.42
+2.87%
155.95
-17.48%
188.99
Selling And Marketing Expense
59.64
+6.18%
56.17
+8.21%
51.91
-16.31%
62.02
General And Administrative Expense
113.86
+9.22%
104.25
+0.20%
104.04
-18.06%
126.97
Salaries And Wages
7.29
-43.60%
12.93
+1.67%
12.72
-7.56%
13.76
Other Gand A
106.57
+16.69%
91.32
0.00%
91.33
-19.33%
113.21
Other Operating Expenses
1.98
-42.50%
3.44
+139.38%
-8.72
-18.10%
-7.38
Total Expenses
367.25
+31.88%
278.48
-7.39%
300.69
-31.77%
440.71
Operating Income
-46.66
-547.21%
10.43
+133.60%
-31.05
+85.84%
-219.38
Total Operating Income As Reported
183.31
+7.50%
170.52
+478.08%
-45.10
+80.51%
-231.45
EBITDA
-40.52
-187.31%
46.41
+519.50%
-11.06
+99.29%
-1,554.65
Normalized EBITDA
-25.90
-173.07%
35.45
+120.07%
16.11
+113.02%
-123.74
Reconciled Depreciation
14.19
+12.60%
12.60
-61.54%
32.77
-65.01%
93.66
EBIT
-54.72
-261.83%
33.81
+177.12%
-43.84
+97.34%
-1,648.31
Total Unusual Items
-14.62
-233.36%
10.96
+140.35%
-27.17
+98.10%
-1,430.91
Total Unusual Items Excluding Goodwill
-14.62
-233.36%
10.96
+140.35%
-27.17
+98.10%
-1,430.91
Special Income Charges
-15.96
-2193.25%
-0.70
+98.19%
-38.46
+97.42%
-1,491.83
Other Special Charges
—
-2.48
-122.57%
10.97
-46.71%
20.58
Impairment Of Capital Assets
15.96
+2193.25%
0.70
-98.11%
36.90
-97.47%
1,458.32
Restructuring And Mergern Acquisition
—
7.45
+190.31%
-8.25
-205.46%
7.83
Write Off
—
—
0.00
-100.00%
5.48
Net Income
-135.96
-8645.82%
1.59
+102.29%
-69.33
+95.96%
-1,717.62
Pretax Income
-56.52
-280.62%
31.30
+154.30%
-57.64
+96.65%
-1,720.12
Net Non Operating Interest Income Expense
4.04
-48.22%
7.80
+897.44%
-0.98
+98.55%
-67.31
Interest Expense Non Operating
1.81
-28.07%
2.52
-81.77%
13.80
-80.79%
71.81
Net Interest Income
4.04
-48.22%
7.80
+897.44%
-0.98
+98.55%
-67.31
Interest Expense
1.81
-28.07%
2.52
-81.77%
13.80
-80.79%
71.81
Interest Income Non Operating
5.85
-43.31%
10.31
-19.55%
12.82
+184.45%
4.51
Interest Income
5.85
-43.31%
10.31
-19.55%
12.82
+184.45%
4.51
Other Income Expense
-13.90
-206.42%
13.06
+151.01%
-25.61
+98.21%
-1,433.44
Other Non Operating Income Expenses
0.72
-65.70%
2.10
+33.95%
1.57
+170.11%
-2.23
Gain On Sale Of Security
1.34
-88.50%
11.66
+3.33%
11.28
-81.48%
60.92
Gain On Sale Of Business
—
—
—
0.00
Tax Provision
2.10
-50.65%
4.25
+866.25%
-0.55
+74.12%
-2.14
Tax Rate For Calcs
0.00
+194.89%
0.00
+1311.20%
0.00
+672.05%
0.00
Tax Effect Of Unusual Items
-5.85
-493.26%
1.49
+669.36%
-0.26
+85.34%
-1.78
Net Income Including Noncontrolling Interests
-135.96
-8645.82%
1.59
+102.29%
-69.33
+95.96%
-1,717.98
Net Income From Continuing Operation Net Minority Interest
-58.62
-316.71%
27.05
+147.39%
-57.08
+96.68%
-1,717.62
Net Income From Continuing And Discontinued Operation
-135.96
-8645.82%
1.59
+102.29%
-69.33
+95.96%
-1,717.62
Net Income Continuous Operations
-58.62
-316.71%
27.05
+147.39%
-57.08
+96.68%
-1,717.98
Net Income Discontinuous Operations
-77.34
-203.80%
-25.46
-107.95%
-12.24
0.00
Minority Interests
0.00
0.00
—
0.35
Normalized Income
-49.85
-383.64%
17.57
+158.25%
-30.17
+89.54%
-288.49
Net Income Common Stockholders
-135.96
-8645.82%
1.59
+102.29%
-69.33
+95.96%
-1,717.62
Diluted EPS
—
0.04
+102.63%
-1.52
+98.10%
-79.90
Basic EPS
—
0.04
+102.63%
-1.52
+98.10%
-79.90
Basic Average Shares
—
54.83
+26.86%
43.22
+101.12%
21.49
Diluted Average Shares
—
54.83
+26.86%
43.22
+101.12%
21.49
Diluted NI Availto Com Stockholders
-135.96
-8645.82%
1.59
+102.29%
-69.33
+95.96%
-1,717.62
Depreciation Amortization Depletion Income Statement
3.81
+27.82%
2.98
-75.09%
11.98
-75.35%
48.60
Depreciation And Amortization In Income Statement
3.81
+27.82%
2.98
-75.09%
11.98
-75.35%
48.60
Earnings From Equity Interest
—
—
—
-0.29
Excise Taxes
21.83
-29.46%
30.95
+4.75%
29.54
-7.57%
31.96
Gain On Sale Of PPE
—
0.50
-56.99%
1.16
+210.46%
0.37
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2022-06-30
Total Assets
601.09
-29.50%
852.67
+1.67%
838.67
-22.66%
1,084.36
Current Assets
397.45
-16.91%
478.33
+12.12%
426.61
-42.75%
745.12
Cash Cash Equivalents And Short Term Investments
116.90
-15.24%
137.92
-1.58%
140.13
-68.09%
439.14
Cash And Cash Equivalents
64.69
-53.10%
137.92
+1.34%
136.09
-68.91%
437.81
Other Short Term Investments
52.21
0.00
-100.00%
4.04
+203.23%
1.33
Receivables
44.58
+4.96%
42.47
-6.48%
45.41
-3.49%
47.05
Accounts Receivable
41.97
+19.84%
35.02
-13.63%
40.54
+41.43%
28.66
Other Receivables
2.61
-40.14%
4.37
+29.99%
3.36
-77.90%
15.19
Taxes Receivable
0.00
-100.00%
3.09
+104.30%
1.51
-52.69%
3.19
Inventory
175.07
-26.78%
239.09
+28.29%
186.38
+33.20%
139.93
Raw Materials
4.70
-58.77%
11.40
-23.92%
14.99
+38.55%
10.82
Work In Process
115.42
+5.88%
109.01
+52.25%
71.60
-14.26%
83.51
Finished Goods
34.74
-48.54%
67.52
+18.42%
57.02
+161.86%
21.77
Prepaid Assets
—
—
—
6.54
Restricted Cash
47.79
+0.81%
47.41
+9.93%
43.13
-15.39%
50.97
Assets Held For Sale Current
1.99
+794.59%
0.22
-84.13%
1.40
-97.73%
61.49
Hedging Assets Current
—
0.00
-100.00%
0.76
—
Other Current Assets
11.12
-0.85%
11.21
+19.28%
9.40
+43.78%
6.54
Total Non Current Assets
203.63
-45.60%
374.34
-9.16%
412.07
+21.47%
339.24
Net PPE
123.69
-53.87%
268.11
-8.91%
294.32
+26.07%
233.47
Gross PPE
292.45
-47.76%
559.77
-0.40%
562.00
-20.77%
709.37
Accumulated Depreciation
-168.76
+42.14%
-291.67
-8.96%
-267.68
+43.75%
-475.90
Properties
0.00
0.00
0.00
0.00
Land And Improvements
14.04
-75.55%
57.43
-0.65%
57.80
+165.23%
21.79
Buildings And Improvements
145.61
-47.57%
277.74
-0.56%
279.30
-36.14%
437.38
Machinery Furniture Equipment
28.38
-28.30%
39.58
+0.88%
39.23
-6.63%
42.02
Construction In Progress
17.46
-35.68%
27.15
+3.13%
26.33
-23.15%
34.26
Other Properties
86.95
-44.92%
157.87
-0.92%
159.33
-8.39%
173.92
Leases
—
—
—
—
Goodwill And Other Intangible Assets
58.09
-34.75%
89.03
+5.96%
84.03
+18.86%
70.70
Goodwill
26.65
-39.25%
43.87
+1.60%
43.18
0.00
Other Intangible Assets
31.44
-30.38%
45.16
+10.56%
40.85
-42.22%
70.70
Investments And Advances
12.11
0.00
—
1.21
Long Term Equity Investment
12.11
0.00
—
1.21
Non Current Accounts Receivable
3.67
-30.27%
5.26
-17.14%
6.34
+43.05%
4.43
Non Current Deferred Assets
2.46
-41.74%
4.22
-72.50%
15.34
0.00
Non Current Deferred Taxes Assets
2.46
-41.74%
4.22
-72.50%
15.34
0.00
Non Current Prepaid Assets
—
—
—
3.13
Other Non Current Assets
3.62
-53.15%
7.72
-35.80%
12.03
+281.84%
3.15
Total Liabilities Net Minority Interest
89.25
-63.43%
244.07
+3.07%
236.80
-43.89%
422.00
Current Liabilities
66.93
-39.63%
110.86
-11.04%
124.62
-4.77%
130.86
Payables And Accrued Expenses
57.55
-29.13%
81.21
+35.10%
60.11
-14.18%
70.04
Payables
19.30
-48.84%
37.73
+53.91%
24.52
+49.68%
16.38
Accounts Payable
9.31
-66.29%
27.62
+35.89%
20.32
+46.67%
13.86
Other Payable
—
0.03
-80.00%
0.14
-89.61%
1.40
Current Accrued Expenses
38.25
-12.02%
43.47
+22.14%
35.59
-33.67%
53.66
Total Tax Payable
9.99
-1.19%
10.11
+149.89%
4.05
+259.09%
1.13
Income Tax Payable
6.96
-8.45%
7.60
+391.34%
1.55
+826.35%
0.17
Current Debt And Capital Lease Obligation
5.73
-78.70%
26.89
-53.00%
57.22
+73.36%
33.00
Current Debt
—
21.51
-58.91%
52.36
+94.98%
26.85
Other Current Borrowings
—
21.51
-58.91%
52.36
+94.98%
26.85
Current Capital Lease Obligation
5.73
+6.47%
5.38
+10.81%
4.86
-21.04%
6.15
Current Deferred Liabilities
1.27
+18.25%
1.07
-36.34%
1.69
-56.18%
3.85
Current Deferred Revenue
1.27
+18.25%
1.07
-36.34%
1.69
-56.18%
3.85
Other Current Liabilities
—
—
—
18.55
Total Non Current Liabilities Net Minority Interest
22.32
-83.24%
133.21
+18.75%
112.18
-61.47%
291.14
Long Term Debt And Capital Lease Obligation
18.13
-76.66%
77.69
+63.30%
47.57
-79.88%
236.49
Long Term Debt
—
40.19
+720.62%
4.90
-97.55%
199.65
Long Term Capital Lease Obligation
18.13
-51.65%
37.49
-12.14%
42.68
+15.85%
36.84
Tradeand Other Payables Non Current
—
—
0.00
-100.00%
14.37
Non Current Deferred Liabilities
0.00
-100.00%
1.90
-88.28%
16.19
+465.69%
2.86
Non Current Deferred Taxes Liabilities
0.00
-100.00%
1.90
-88.28%
16.19
+465.69%
2.86
Other Non Current Liabilities
0.50
-98.96%
48.09
+4.30%
46.11
+35923.44%
0.13
Stockholders Equity
511.83
-9.76%
567.17
+1.32%
559.77
-15.42%
661.84
Common Stock Equity
511.83
-9.76%
567.17
+1.32%
559.77
-15.42%
661.84
Capital Stock
7,007.23
+0.23%
6,991.15
+0.28%
6,971.42
+3.21%
6,754.63
Common Stock
7,007.23
+0.23%
6,991.15
+0.28%
6,971.42
+3.21%
6,754.63
Share Issued
58.95
+4.83%
56.23
+3.10%
54.55
+83.18%
29.78
Ordinary Shares Number
58.95
+4.83%
56.23
+3.10%
54.55
+83.18%
29.78
Retained Earnings
-6,441.91
-1.16%
-6,367.74
+0.00%
-6,367.94
-5.46%
-6,038.27
Gains Losses Not Affecting Retained Earnings
-53.49
+4.89%
-56.24
-28.67%
-43.71
+19.82%
-54.51
Minority Interest
0.00
-100.00%
41.42
-1.61%
42.10
+8138.16%
0.51
Other Equity Adjustments
-53.49
+4.89%
-56.24
-28.67%
-43.71
+19.82%
-54.51
Total Equity Gross Minority Interest
511.83
-15.90%
608.59
+1.12%
601.87
-9.13%
662.35
Total Capitalization
511.83
-15.73%
607.37
+7.56%
564.67
-34.45%
861.49
Working Capital
330.52
-10.05%
367.46
+21.68%
301.99
-50.84%
614.26
Invested Capital
511.83
-18.61%
628.88
+1.92%
617.03
-30.54%
888.35
Total Debt
23.86
-77.19%
104.58
-0.20%
104.79
-61.12%
269.49
Capital Lease Obligations
23.86
-44.35%
42.88
-9.80%
47.53
+10.57%
42.99
Net Tangible Assets
453.74
-5.10%
478.14
+0.50%
475.74
-19.52%
591.15
Tangible Book Value
453.74
-5.10%
478.14
+0.50%
475.74
-19.52%
591.15
Current Provisions
2.38
+40.91%
1.69
-69.87%
5.61
+3.62%
5.41
Derivative Product Liabilities
3.70
-33.16%
5.53
+139.54%
2.31
-93.81%
37.30
Financial Assets
—
—
0.00
-100.00%
26.28
Non Current Note Receivables
—
—
—
0.02
Other Inventories
20.21
-60.50%
51.17
+19.62%
42.77
+79.52%
23.83
Line Item Trend 2026-03-31 2025-03-31 2024-03-31 2022-06-30
Operating Cash Flow
-13.51
-184.41%
16.01
+123.36%
-68.51
+37.87%
-110.27
Cash Flow From Continuing Operating Activities
-7.83
-141.27%
18.97
+130.03%
-63.17
+42.72%
-110.27
Cash From Discontinued Operating Activities
-5.68
-91.80%
-2.96
+44.53%
-5.34
0.00
Net Income From Continuing Operations
-58.62
-316.71%
27.05
+147.39%
-57.08
+96.68%
-1,717.98
Depreciation Amortization Depletion
14.19
+12.60%
12.60
-61.54%
32.77
-65.01%
93.66
Depreciation
13.38
+8.91%
12.29
-61.45%
31.87
-47.03%
60.17
Amortization Cash Flow
0.81
+156.51%
0.32
-65.04%
0.90
-97.31%
33.49
Depreciation And Amortization
14.19
+12.60%
12.60
-61.54%
32.77
-65.01%
93.66
Amortization Of Intangibles
0.81
+156.51%
0.32
-65.04%
0.90
-97.31%
33.49
Other Non Cash Items
24.06
+174.20%
-32.43
+54.60%
-71.44
-216.73%
-22.55
Stock Based Compensation
7.29
-36.71%
11.52
-9.38%
12.72
-7.56%
13.76
Asset Impairment Charge
15.96
+2193.25%
0.70
-98.11%
36.90
-97.50%
1,474.31
Deferred Tax
0.06
+101.74%
-3.15
-89.08%
-1.67
+23.99%
-2.19
Deferred Income Tax
0.06
+101.74%
-3.15
-89.08%
-1.67
+23.99%
-2.19
Operating Gains Losses
-1.56
+86.49%
-11.53
-6842.11%
0.17
+108.93%
-1.92
Net Foreign Currency Exchange Gain Loss
-1.56
+86.49%
-11.53
-6842.11%
0.17
+108.93%
-1.92
Change In Working Capital
-9.21
-164.86%
14.21
+191.40%
-15.54
-129.52%
52.65
Change In Receivables
-8.15
-295.05%
4.18
+192.82%
-4.50
-124.55%
18.34
Changes In Account Receivables
-8.15
-295.05%
4.18
+192.82%
-4.50
-124.55%
18.34
Change In Inventory
7.44
+468.27%
-2.02
-152.17%
3.87
-81.62%
21.07
Change In Prepaid Assets
-0.76
+57.61%
-1.80
-228.47%
-0.55
-120.49%
2.67
Change In Payables And Accrued Expense
-8.23
-154.87%
15.00
+203.66%
-14.47
-303.95%
7.10
Change In Payable
-8.23
-154.87%
15.00
+203.66%
-14.47
-303.95%
7.10
Change In Account Payable
-8.04
-212.82%
7.13
+145.41%
-15.70
-332.11%
6.76
Change In Other Working Capital
0.49
+142.42%
-1.16
-1169.44%
0.11
-94.30%
1.89
Change In Other Current Liabilities
—
—
-0.03
-101.58%
1.58
Investing Cash Flow
-72.61
-406.76%
-14.33
-326.05%
-3.36
+90.70%
-36.17
Cash Flow From Continuing Investing Activities
-72.84
-513.78%
-11.87
-297.45%
-2.99
+91.74%
-36.17
Cash From Discontinued Investing Activities
0.23
+109.55%
-2.46
-552.52%
-0.38
0.00
Net PPE Purchase And Sale
-21.45
-64.07%
-13.07
-186.81%
-4.56
+63.72%
-12.56
Purchase Of PPE
-22.55
-49.76%
-15.05
+10.57%
-16.83
+47.74%
-32.21
Sale Of PPE
1.10
-44.67%
1.98
-83.86%
12.28
-37.52%
19.65
Capital Expenditure
-22.55
-49.76%
-15.05
+10.57%
-16.83
+47.74%
-32.21
Net Investment Purchase And Sale
-52.21
-1051.40%
5.49
+9.91%
4.99
0.00
Purchase Of Investment
-52.21
0.00
—
0.00
Sale Of Investment
0.00
-100.00%
5.49
+9.91%
4.99
0.00
Net Business Purchase And Sale
—
0.00
+100.00%
-5.54
+76.32%
-23.42
Purchase Of Business
—
0.00
+100.00%
-5.54
+76.32%
-23.42
Net Other Investing Changes
0.82
+119.10%
-4.28
-301.65%
2.12
+1248.11%
-0.18
Financing Cash Flow
9.76
+8514.66%
-0.12
+99.76%
-47.92
-132.43%
147.78
Cash Flow From Continuing Financing Activities
4.90
+210.77%
-4.42
+90.68%
-47.45
-132.11%
147.78
Net Issuance Payments Of Debt
-5.02
+4.22%
-5.24
+93.86%
-85.37
+50.03%
-170.83
Issuance Of Debt
—
11.68
-19.69%
14.54
0.00
Repayment Of Debt
-5.02
+4.22%
-5.24
+94.76%
-99.92
+41.51%
-170.83
Long Term Debt Issuance
—
11.68
-19.69%
14.54
0.00
Long Term Debt Payments
-5.02
+4.22%
-5.24
+94.76%
-99.92
+41.51%
-170.83
Net Long Term Debt Issuance
-5.02
+4.22%
-5.24
+93.86%
-85.37
+50.03%
-170.83
Net Common Stock Issuance
10.91
0.00
-100.00%
37.92
-89.17%
350.19
Proceeds From Stock Option Exercised
0.59
-28.41%
0.82
0.00
—
Net Other Financing Charges
-1.58
—
—
-31.58
Changes In Cash
-76.36
-4988.54%
1.56
+101.30%
-119.79
-9033.18%
1.34
Effect Of Exchange Rate Changes
3.13
+1084.85%
0.26
-11.11%
0.30
-98.02%
15.01
Beginning Cash Position
137.92
+1.34%
136.09
-46.75%
255.59
-39.36%
421.46
End Cash Position
64.69
-53.10%
137.92
+1.34%
136.09
-68.91%
437.81
Free Cash Flow
-36.06
-3887.39%
0.95
+101.12%
-85.34
+40.10%
-142.48
Interest Paid Supplemental Data
2.35
-19.43%
2.92
-80.34%
14.87
-46.38%
27.73
Income Tax Paid Supplemental Data
0.76
-18.21%
0.93
0.00
—
Change In Income Tax Payable
-0.19
-102.38%
7.87
+540.00%
1.23
+271.60%
0.33
Change In Tax Payable
-0.19
-102.38%
7.87
+540.00%
1.23
+271.60%
0.33
Common Stock Issuance
10.91
0.00
-100.00%
37.92
-89.17%
350.19
Issuance Of Capital Stock
10.91
0.00
-100.00%
37.92
-89.17%
350.19
Other Cash Adjustment Outside Changein Cash
—
—
0.12
—
Sale Of Business
—
—
—
—
Cash From Discontinued Financing Activities
4.87
+13.03%
4.30
+1006.11%
-0.47
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category